Intensive Monitoring Studies for Assessing Medicines: A Systematic Review

Frontiers in Medicine
Carla TorreAna Paula Martins

Abstract

Introduction: Intensive monitoring (IM) is one of the methods of post-marketing active surveillance based upon event monitoring, which has received interest in the current medicines regulatory landscape. For a specific period of time, IM involves primary data collection and is actively focused on gathering longitudinal information, mainly safety, since the first day of drug use. Objectives: To describe IM systems and studies' data published over 11-years period (2006-2016). Specifically, we reviewed study population/event surveillance, methodological approaches, limitations, and its applications in the real-world evidence generation data. Methods: We completed a systematic search of MEDLINE and EMBASE to identify studies published from 2006 to 2016, that used IM methodology. We extracted data using a standardized form and results were analyzed descriptively. The methodological quality of selected studies was assessed using the modified Downs and Black checklist. Results: From 1,400 screened citations, we identified 86 papers, corresponding to 69 different studies. Seventy percent of reviewed studies corresponded to established IM systems, of which, more than half were prescription event monitoring (PEM) and modified-PEM. Among ...Continue Reading

References

Sep 18, 1982·British Medical Journal·W H Inman
Aug 31, 1996·BMJ : British Medical Journal·T C EgbertsH G Leufkens
Apr 11, 2001·European Journal of Clinical Pharmacology·K KubotaK Kurokawa
Jun 20, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kiyoshi Kubota
Sep 12, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kazuo SamizoKiyoshi Kubota
Mar 6, 2003·Pharmacoepidemiology and Drug Safety·Patrick C Waller, Stephen J W Evans
Jan 1, 1965·Journal of Chronic Diseases·D J FINNEY
Sep 23, 2003·Health Technology Assessment : HTA·J J DeeksUNKNOWN European Carotid Surgery Trial Collaborative Group
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·D M Coulter
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·K Kubota
Jul 3, 2004·BMJ : British Medical Journal·Bruno H Ch Stricker, Bruce M Psaty
Mar 23, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·N V AcharyaS A W Shakir
May 13, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Lorna Hazell, Saad A W Shakir
Jul 22, 2006·American Journal of Therapeutics·Vanina BongardLapeyre-Mestre Maryse
Jul 29, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Deborah LaytonSaad A W Shakir
Sep 26, 2006·International Journal of Clinical Pharmacology and Therapeutics·M SchulzA Gillissen
Jan 27, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rachna KasliwalSaad A W Shakir
Apr 6, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Alexander N O DodooAugustina Appiah-Danquah
May 3, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Beverley R TwaitesSaad A W Shakir
Jul 3, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Mira Harrison-WoolrychPeter Herbison
Jul 10, 2007·European Journal of Clinical Pharmacology·Juliet M FosterLolkje de Jong-van den Berg
Jul 28, 2007·Journal of Psychopharmacology·Beverley R TwaitesSaad A W Shakir
Jul 31, 2007·Pharmacoepidemiology and Drug Safety·Geraldine R HillMira Harrison-Woolrych
Aug 19, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Michael J PerrioSaad A W Shakir
Sep 14, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Giuseppe Vittorio L De SocioUNKNOWN CISAI Study Group
Sep 29, 2007·Contraception·Helen PatersonMira Harrison-Woolrych
Nov 27, 2007·Clinical Therapeutics·Robert J LigthelmPaul Valensi
Nov 30, 2007·The New England Journal of Medicine·Jerry Avorn
Mar 20, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mercedes M SniadackGina T Mootrey
Mar 28, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Miranda DaviesSaad A W Shakir
Apr 9, 2008·BMJ : British Medical Journal·Bob Roehr
Apr 12, 2008·Journal of Natural Medicines·Virginia Claudia da SilvaAline Nogueira Alves
May 20, 2008·Travel Medicine and Infectious Disease·Li HuaFeng Xinwen
Jun 5, 2008·European Journal of Clinical Pharmacology·L Härmark, A C van Grootheest
Jul 16, 2008·Journal of Natural Medicines·Etsuko SueyoshiHideaki Otsuka
Aug 19, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Yurdaguel ZopfHarald Dormann
Sep 2, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rachna KasliwalSaad A W Shakir
Sep 13, 2008·Nature Reviews. Drug Discovery·Hans-Georg EichlerAlasdair Breckenridge

❮ Previous
Next ❯

Software Mentioned

IMMP
OVID SP
PEM
OBSERVA
Excel®

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
L A RonaldD Menzies
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Ashraf Ghiasi
© 2021 Meta ULC. All rights reserved